Our latest strategic in silico session
is now available to watch!

Discover how in silico methods can be used to assess safety
based on the drug target biology as well as the chemical. 

Watch Now

Managing SEND Just Got Easier

We are excited to introduce SEND Advantage™ Services. Offering study conversions, compliance services and consulting, our new and refreshed services have been designed to help organizations maintain SEND compliance and more. Watch our on-demand video right now.

Watch Now

Drug Target Review Interviews Instem CSO

Instem CSO, Dr Gordon Baxter, was recently interviewed by Drug Target Review
for an in-depth editorial on Target Safety Assessment.

Download the article

Industry Insights

Join the journey with us by visiting
one of our bi-weekly industry Blogs

Learn More

The future transformed for the benefit of everyone.

Intelligent solutions empowering collaboration and life-enhancing science.


Latest News

Instem Unveils New Additions to its Leading Computational Toxicology Software Suite

New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety

Read More

Instem Awarded EMA Research Grant

Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

Read More

Instem Expands In Silico Toxicology Service To Meet Growing Demand

Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods

Read More

Virtual Appointment

Request a quote

Virtual Appointment

To help you better evaluate our software or services, we believe an initial, no pressure Web session is the way to go.

Request a quote

We are excited that you have decided to take the next step with Instem. To provide you with an accurate quotation, we ask that you fill out our form.